Latest Technology News

AdAlta says a 10-year, up to US$120 million agreement between manufacturing partner Oribiotech and an undisclosed commercial-stage biopharmaceutical company validates its choice of IRO automation for future cellular immunotherapies. The deal does not create direct revenue for AdAlta, and its lead asset EW-001 will continue with a separate manufacturing process.

MyState delivered a sharp rise in FY26 profit as Auswide integration produced $11.8 million in run-rate synergies, while the group lifted its full-year dividend to 24.5 cents per share. The next test is turning early integration gains into a larger payoff without losing control of technology costs and credit risk.

Acumentis delivered a sharp improvement in profit and cash generation despite lower revenue, supported by cost control and diversification beyond mortgage valuations. The result comes with a governance complication: a Section 249D requisition seeking to replace the chairman and managing director.

Dataworks Group has lodged a prospectus for a non-renounceable entitlement offer targeting A$1.24 million, alongside a committed A$3 million placement. The raising would fund debt repayment, working capital and contract mobilisation, but also materially expand the company’s share count and option pool.

CurveBeam AI has raised A$1.75 million through an oversubscribed SPP shortfall offer and placement, lifting its recent capital raised to A$7.36 million. The funds will support the HiRise China launch, product development, supply-chain preparation and working capital.

Argo Investments delivered an 8.7% portfolio return and record fully franked dividends in FY2026, while flagging a shift to quarterly distributions from January. The listed investment company intends to pay 40 cents per share across its first four quarterly dividends, subject to Board declarations.

Austco Healthcare delivered record FY26 revenue and statutory profit, with stronger margins, cash generation and a modest recovery in contracted orders entering the new financial year. The company is pairing that momentum with further reseller consolidation, including the $2.88 million acquisition of Medical Communications Systems.

Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.

Rox Resources has crossed the line from explorer to mine developer, with Youanmi underground mining underway, the processing plant under construction and a target of first gold in mid-2027. The project is financed on paper, but the A$350 million debt package remains subject to conditions precedent and the construction schedule still has to survive execution.

Codan Limited (ASX:CDA) has entered FY27 with record revenue, profit and a sharply larger Communications orderbook, while targeting approximately 20% Communications revenue growth. The forecast is conditional on supply-chain capacity as demand for unmanned systems and new gold detectors accelerates.

Bridge SaaS has told ASX it knows of no undisclosed information behind a sharp share price fall and significant increase in trading volume. The response confirms compliance with continuous disclosure rules but leaves the market activity unexplained.

Hydrix has secured a three-year contract with Singapore’s National Heart Centre to deploy the Implicity remote cardiac monitoring platform. The agreement is expected to generate about A$0.625 million, although the final value depends on patient volumes and implementation.